Medley

Medley FCF per Share

The Free Cash Flow per Share of Medley (4480.T) as of Oct 15, 2026 is 96.73 JPY. In the previous year, Free Cash Flow per Share was 72.75 JPY — a change of 32.96% (higher).

FCF per Share

96.73JPY

YoY

32.96%

Last updated:

Free Cash Flow per Share of Medley is 2025 96.73 JPY. Free Cash Flow per Share of Medley was 2024 72.75 JPY. It decreases by 32.96% higher compared to the previous year.

The Medley FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.24 JPY
Jan 1, 2019
12.12 JPY
Jan 1, 2020
19.11 JPY
Jan 1, 2021
24.59 JPY
Jan 1, 2022
49.57 JPY
Jan 1, 2023
106.22 JPY
Jan 1, 2024
72.75 JPY
Jan 1, 2025
96.73 JPY
The Medley FCF per Share history
YEARFCF per ShareYoY
96.73JPY+32.96%
72.75JPY-31.51%
106.22JPY+114.27%
49.57JPY+101.59%
24.59JPY+28.65%
19.11JPY+57.77%
12.12JPY-5,185.61%
-0.24JPY-120.30%
1.17JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medley Stock analysis

What does Medley do? Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society. Medley is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medley stock

Free Cash Flow per Share of Medley is 96.73 JPY in 2025.

Free Cash Flow per Share of Medley changed from 72.75 JPY to 96.73 JPY, representing a 32.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Medley since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medley

All Key Metrics — Medley